Is Diarrhea Associated with Bisoprolol as an Alternative?
Bisoprolol is associated with diarrhea, but at similar or even lower rates than placebo, making it a reasonable alternative to propranolol for a patient experiencing gastrointestinal side effects.
Evidence from FDA Drug Labels
According to the FDA label for bisoprolol, diarrhea occurred in 2.6% of patients taking 5-20 mg doses and 3.5% at doses of 2.5-40 mg, compared to 1.5% on placebo 1. Importantly, diarrhea appears to be dose-related with bisoprolol 1. In contrast, propranolol's FDA label lists diarrhea as an adverse event without specific frequency data, alongside other gastrointestinal effects including nausea, vomiting, epigastric distress, abdominal cramping, and constipation 2.
Key Clinical Context
A systematic review of placebo-controlled beta-blocker trials in heart failure provides crucial perspective: of 100 patients developing diarrhea on beta-blockers, 82 would have experienced it on placebo anyway (95% CI 70-95) 3. This means diarrhea is predominantly not a pharmacological effect of beta-blockers but rather a symptom that occurs regardless of treatment.
Bisoprolol as a Specific Alternative
Bisoprolol has been successfully used as an alternative beta-blocker in patients with adverse reactions to propranolol. A 2024 case report documented a patient who developed urticaria with propranolol but tolerated bisoprolol without issues during drug provocation testing 4. While this case involved an allergic reaction rather than gastrointestinal symptoms, it demonstrates bisoprolol's utility as a well-tolerated alternative.
Practical Considerations
- Bisoprolol is cardioselective (β1-selective), which may offer advantages in tolerability compared to the non-selective propranolol 5
- The drug has 90% oral bioavailability and allows once-daily dosing, which may improve adherence 6
- Start at 2.5-5 mg daily and titrate gradually to minimize dose-related side effects including diarrhea 5, 1
Regarding Midodrine
The FDA label for midodrine does not list diarrhea as an adverse effect 7. Its primary side effects relate to alpha-adrenergic stimulation (supine hypertension, paresthesia, pruritus, urinary symptoms). If the patient's diarrhea and nausea were specifically related to midodrine, this would be unusual and not a recognized pharmacological effect.
Clinical Recommendation
Switch to bisoprolol starting at 2.5-5 mg daily. The likelihood of developing new or persistent diarrhea specifically from bisoprolol is low, as the drug shows minimal excess risk compared to placebo. Monitor for the dose-related side effects that are genuinely attributable to bisoprolol: bradycardia (which occurs in only 33% of symptomatic patients due to the drug itself) 3. If gastrointestinal symptoms persist after switching, consider that they may be unrelated to beta-blocker therapy and investigate other causes.